Comparing the design of two recent mesalazine trials with respect to EMA guideline on the development of new medicinal products for the treatment of Ulcerative Colitis

RaphaĆ«l Laoun  1     Robert Hofmann  1    
1 Tillotts Pharma AG,Rheinfelden,Switzerland

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing